Invivyd, Inc. granted stock options for 175,000 shares to seven newly hired non-executive employees as an inducement for joining the company. The options, priced at $0.5817 per share, vest over four years and have a 10-year term. This move aligns with Nasdaq Listing Rule 5635(c)(4) and supports Invivyd's growth by attracting talent. Invivyd is a biopharmaceutical firm focused on viral disease protection, including COVID-19 antibody development.
Invivyd's inducement grants come as a backdrop to a mixed health sector market on Pluang, where 74 of 150 priced US health stocks rose and 69 fell as of Nov 03, 2026 19:02 WIB. Notable movers include INO (Inovio Pharmaceuticals Inc) down 5.56% at USD 1.78 with a typical hold time of 42 days, NUWE (Nuwellis Inc) down 5.41% at USD 4.90 with a 30-day hold, and AHCO (AdaptHealth Corp) up 4.91% at USD 6.20 with a 21-day hold. Pluang order activity shows a near balance on INO and NUWE, while AHCO sees strong buying interest at 90%.
Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...
Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...
Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...
Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...
Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...
